oasis 1 oral semaglutide 50 mg obesity lancet 2023 of #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Semaglutide as a GLP-1 Agonist:

While rare, these complications require immediate medical attention and careful monitoring during treatment

In addition, a main effect of sex ( 2 (1) = 6.382, p = 0.012, f = 0.68) was observed with males having higher BrAC, overall

Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors

These are not guaranteed triggers, but they create conditions where migraines become more likely

Side effects Common side effects of this drug are: Abdominal pain Constipation Decreased appetite Vomiting Nausea Diarrhea Precautions and Warnings Pregnancy Semaglutide safety during pregnancy is uncertain due to limited data

You also found that your TSH was low and your free T4 was high after thyroid blood testing